Eli Lilly says its injectables pipeline and Trump-era tax laws prompted the decision to build new plant in North Carolina. Earlier this week Lilly announced it would build an injectable drug manufacturing facility in Durham County, North Carolina as part of a $470 m investment. The facility located at Research Triangle park will make injectable drugs and delivery devices according to Lilly, which said it expects to create more than 460 new jobs. A Lilly spokeswoman told us “The new…